Summary
Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring (PCM) technology to detect and monitor circulating tumor DNA (ctDNA) in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Trovagene is headquartered in San Diego, California, the US.
Trovagene Inc (TROV) - Medical Equipment - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Trovagene Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Trovagene Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Trovagene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Trovagene Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12
Venture Financing 13
TrovaGene Secures USD15 Million in Venture Funding 13
Partnerships 14
Trovagene Enters Into Licensing Agreement with GenSignia IP 14
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 14
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 15
Trovagene Enters into Agreement with Novogene 16
Trovagene Enters into Agreement for Trovera 17
Trovagene Enters into Agreement with AstraZeneca 17
Trovagene Enter into Agreements for Trovera 18
Trovagene Enters into Agreement with Boreal Genomics 19
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 20
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 21
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 21
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 23
Equity Offering 24
Trovagene to Raise USD7 Million in Private Placement of Shares and Warrants 24
Trovagene Raises USD40.3 Million in Public Offering of Shares 25
Trovagene Completes Public Offering of Shares for USD23 Million 26
Trovagene Completes Private Placement Of Shares For US$15 Million 27
Trovagene Completes Private Placement Of Units For US$4 Million 28
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 29
Trovagene Inc - Key Competitors 31
Key Employees 32
Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Strategy And Business Planning 34
Aug 18, 2016: Blue Cross Blue Shield Illinois to cover Trovera liquid biopsy tests 34
Feb 22, 2016: Trovagene Enters into Preferred Provider Agreement with Fortified Provider Network 35
Feb 01, 2016: Trovagene Enters into Agreement with FedMed and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform 36
Jan 21, 2016: Trovagene Announces Agreement with America's Choice Provider Network to Offer Patients Access to its ctDNA Precision Cancer Monitoring Platform 37
Financial Announcements 38
May 10, 2017: Trovagene Announces First Quarter 2017 Company Highlights and Financial Results 38
Mar 15, 2017: Trovagene Reports Fourth Quarter and Year End 2016 Financial Results 40
Nov 09, 2016: Trovagene Reports Third Quarter 2016 Financial Results and Accomplishments 41
Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments 43
May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results 44
Mar 10, 2016: Trovagene Announces Fourth Quarter and Year End 2015 Financial Results 46
Corporate Communications 48
Apr 13, 2017: Trovagene Announces the Addition of Dr. Sandra Silberman to its Clinical Advisory Board 48
Apr 25, 2016: Trovagene Appoints Bill Welch as Chief Executive Officer 50
Mar 28, 2016: Trovagene Terminates the Employment of CEO Antonius Schuh and CFO Stephen Zaniboni for Cause 51
Legal and Regulatory 52
Jul 10, 2017: Trovagene Regains Compliance with NASDAQ Listing Requirements 52
Product News 53
Sep 09, 2016: Trovagene to Present at the 3rd Annual Precision Medicine Congress 53
May 19, 2016: Large Clinical Data Set in Lung Cancer Featuring Trovagene's Precision Cancer Monitoring Platform Selected for Oral Presentation at the 2016 ASCO Annual Meeting 54
Mar 24, 2016: Clinical Study Results Featuring Trovagene's Precision Cancer Monitoring Platform to be Presented at the AACR Annual Meeting 2016 55
Mar 08, 2016: Presentation at the Molecular Medicine Tri-Conference to Highlight Clinical Performance of Trovagene's Precision Cancer Monitoring Platform 56
Other Significant Developments 57
Jul 12, 2017: Trovagene Announces Agreement with Novogene for NextCollect in China 57
Jun 22, 2017: Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera ctDNA Tests and Services in Cancer Clinical Trials 58
Jan 12, 2017: Trovagene Announces Broadening Network of Commercial Distributors 59
Dec 13, 2016: Trovagene announces a reorganization to accelerate global distribution of liquid biopsy technology 60
Aug 17, 2016: BCBS Illinois expands patient access to Trovera tests for 8.1 million covered lives 61
Apr 11, 2016: Trovagene Enters Into Preferred Provider Agreement with Stratose PPO Network 62
Mar 01, 2016: Trovagene Enters Into Preferred Provider Agreement with Multiplan 63
Feb 24, 2016: Trovagene Enters into Preferred Provider Agreement with Three Rivers Provider Network 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
List of Tables
Trovagene Inc, Medical Equipment, Key Facts, 2016 1
Trovagene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Trovagene Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Trovagene Inc, Deals By Market, 2011 to YTD 2017 9
Trovagene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
TrovaGene Completes Acquisition Of CLIA-Certified Lab From MultiGEN Diagnostics 12
TrovaGene Secures USD15 Million in Venture Funding 13
Trovagene Enters Into Licensing Agreement with GenSignia IP 14
Trovagene Enters Into Licensing Agreement With Strand Life Sciences For HPV Test 14
TrovaGene Enters Into Licensing Agreement With Brunangelo Falini 15
Trovagene Enters into Agreement with Novogene 16
Trovagene Enters into Agreement for Trovera 17
Trovagene Enters into Agreement with AstraZeneca 17
Trovagene Enter into Agreements for Trovera 18
Trovagene Enters into Agreement with Boreal Genomics 19
Trovagene Enters into Agreement with USC Norris Comprehensive Cancer Center 20
Trovagene Enters into Research Agreement with University of Michigan Comprehensive Cancer Center 21
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 21
TrovaGene Enters Into Licensing Agreement With Amedeo Avogadro University And Sapienza University 23
Trovagene to Raise USD7 Million in Private Placement of Shares and Warrants 24
Trovagene Raises USD40.3 Million in Public Offering of Shares 25
Trovagene Completes Public Offering of Shares for USD23 Million 26
Trovagene Completes Private Placement Of Shares For US$15 Million 27
Trovagene Completes Private Placement Of Units For US$4 Million 28
Trovagene Completes Exercise Of Underwriters' Option For Public Offering Of Units For US$10.6 Million 29
Trovagene Inc, Key Competitors 31
Trovagene Inc, Key Employees 32
Trovagene Inc, Subsidiaries 33
List of Figures
Trovagene Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Trovagene Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Trovagene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Trovagene Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Trovagene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Trovagene Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
